Back to mobile site

XOMA completes acquisition of LAVA Therapeutics for $1.04 per share

November 21, 2025 7:45 AM EST Send to a Friend
XOMA Royalty Corporation (NASDAQ: XOMA) completed its acquisition of LAVA Therapeutics N.V. (NASDAQ: LVTX), the company announced November 21. LAVA ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login